Skip to Content

UK Edition. Click here for US version.

ANGELIQ FILM-COATED TABLETS

Active substance(s): DROSPIRENONE / ESTRADIOL / ESTRADIOL HEMIHYDRATE

PDF options:  View Fullscreen   Download PDF

PDF Transcript

43_02.indd cover1

3/27/2017 9:52:06 AM

Packaging Technology Berlin sgqwx
page U 1
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C / Pantone 2612 C / Pantone 257 C / Pantone 123 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

film-coated tablets
Estradiol + Drospirenone

43_02.indd cover2

3/27/2017 9:52:19 AM

Packaging Technology Berlin sgqwx
page U 2
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C / Pantone 2612 C / Pantone 257 C / Pantone 123 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

43_02.indd cover3

3/27/2017 9:52:19 AM

Packaging Technology Berlin sgqwx
page U 3
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C / Pantone 2612 C / Pantone 257 C / Pantone 123 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

43_02.indd cover4

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page U 4
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C / Pantone 2612 C / Pantone 257 C / Pantone 123 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

85675443

43_02.indd 1

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page 1
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

1

Package booklet: Information for the user
Read all of this booklet carefully before you
start taking this medicine because it contains
important information for you.
R Keep this booklet. You may need to read it again.
R If you have any further questions, ask your
doctor or pharmacist.
R This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them,
even if their signs of illness are the same as
yours.

43_02.indd 2

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page 2
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

2

R If you get any side effects, talk to your doctor
or pharmacist. This includes any possible side
effects not listed in this booklet. See section 4.

43_02.indd 3

31

10
10
12
17
22

7

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page 3
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

3

What is in this booklet
1. What Angeliq is and what it is used for
2. What you need to know before you
take Angeliq
Medical history and regular check-ups
Do not take Angeliq
Warnings and precautions
HRT and cancer
Effects of HRT on your heart or
circulation

43_02.indd 4

41
44
47
48
48
49
50
50
52
53

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page 4
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

4

Other conditions
Other medicines and Angeliq
Laboratory tests
Pregnancy and breast-feeding
Driving or using machines
Angeliq contains lactose
3. How to take Angeliq
About the pack
When to start
If you take more Angeliq than you should

43_02.indd 5

69

53
54
55
56
68

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page 5
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

5

If you forget to take Angeliq
If you stop taking Angeliq
If you need to have surgery
4. Possible side effects
5. How to store Angeliq
6. Contents of the pack and other
information

43_02.indd 6

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page 6
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

6

43_02.indd 7

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page 7
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

7

Angeliq is a Hormone Replacement Therapy (HRT).
It contains two types of female hormone, an
oestrogen and a progestogen. Angeliq is used in
postmenopausal women with at least 12 months
(1 year) since their last natural period.

1. What Angeliq is and what it is used for

43_02.indd 8

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page 8
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

8

Relief of symptoms occurring after menopause
During the menopause, the amount of the
oestrogen produced by a woman’s body drops.
This can cause symptoms such as hot face, neck
and chest (“hot flushes”). Angeliq alleviates these
symptoms after menopause. You will only be
prescribed Angeliq if your symptoms seriously
hinder your daily life.

What Angeliq is used for

43_02.indd 9

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page 9
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

9

Prevention of osteoporosis
After the menopause, some women may develop
fragile bones (osteoporosis). You should discuss all
available options with your doctor.
If you are at an increased risk of fractures due
to osteoporosis and other medicines are not
suitable for you, you can use Angeliq to prevent
osteoporosis after menopause.

43_02.indd 10

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page 10
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

10

Medical history and regular check-ups
The use of HRT carries risks which need to be
considered when deciding whether to start taking
it, or whether to carry on taking it.
The experience in treating women with a premature
menopause (due to ovarian failure or surgery) is
limited. If you have a premature menopause the
risks of using HRT may be different. Please talk to
your doctor.

2. What you need to know before you take
Angeliq

43_02.indd 11

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page 11
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

11

Before you start (or restart) HRT, your doctor will
ask about your own and your family’s medical
history. Your doctor may decide to perform
a physical examination. This may include an
examination of your breasts and/or an internal
examination, if necessary.
Once you have started on Angeliq, you should see
your doctor for regular check-ups (at least once a
year). At these check-ups, discuss with your doctor
the benefits and risks of continuing with Angeliq.

43_02.indd 12

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page 12
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

12

Do not take Angeliq
if any of the following applies to you. If you are not
sure about any of the points below, talk to your
doctor before taking Angeliq.

Be sure to:
R go for regular breast screening and cervical
smear tests.
R regularly check your breasts for any changes
such as dimpling of the skin, changes in the
nipple, or any lumps you can see or feel.

43_02.indd 13

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page 13
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

13

Do not take Angeliq
R if you have or have ever had breast cancer, or if
you are suspected of having it
R if you have cancer which is sensitive to
oestrogens, such as cancer of the womb lining
(endometrium) or if you are suspected of having
it
R if you have any unexplained vaginal bleeding
R if you have excessive thickening of the womb
lining (endometrial hyperplasia) that is not
being treated

43_02.indd 14

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page 14
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

14

R if you have or have ever had a blood clot in
a vein (thrombosis) such as in the legs (deep
venous thrombosis) or the lungs (pulmonary
embolism)
R if you have a blood clotting disorder (such as
protein C, protein S, or antithrombin deficiency)
R If you have or recently have had a disease
caused by blood clots in the arteries, such as a
heart attack, stroke or angina
R if you have or have ever had a liver disease and
your liver function tests have not yet returned
to normal

43_02.indd 15

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page 15
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

15

R if you have a rare blood problem called
“Porphyria” which is passed down in families
(inherited)
R if you have severe kidney disease or acute
kidney failure
R if you are allergic (hypersensitive) to
oestrogens, progestogens or any of the other
ingredients of Angeliq (listed in section 6)

43_02.indd 16

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page 16
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

16

R if you have any reason to believe that you
either are, or may be, pregnant, or if you are
producing milk (lactating) and breast-feeding.
(See also the 'Pregnancy and breast-feeding'
section of this booklet)
R If any of the above conditions appear for the
first time while taking Angeliq, stop taking it
at once and consult your doctor immediately.

43_02.indd 17

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page 17
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

17

Warnings and precautions
Talk to your doctor or pharmacist before taking
Angeliq.
Tell your doctor if you have ever had any of the
following problems, before you start the treatment,
as these may return or become worse during
treatment with Angeliq. If so, you should see your
doctor more often for check-ups:
R fibroids inside your womb
R growth of womb lining outside your womb
(endometriosis) or a history of excessive growth
of the womb lining (endometrial hyperplasia)

43_02.indd 18

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page 18
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

18

R increased risk of developing blood clots (see
"Blood clots in a vein (thrombosis)")
R increased risk of getting an oestrogen-sensitive
cancer (such as a mother, sister or grandmother
who has had breast cancer)
R high blood pressure
R a liver disorder, such as benign liver tumour
R diabetes
R gallstones
R migraine or severe headaches

43_02.indd 19

3/27/2017 9:52:20 AM

Packaging Technology Berlin sgqwx
page 19
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

19

R a disease of the immune system that affects
many organs of the body (systemic lupus
erythematosus, SLE)
R epilepsy
R asthma
R a disease affecting the eardrum and hearing
(otosclerosis)
R a very high level of fat in your blood
(triglycerides)
R fluid retention due to cardiac or kidney problems

43_02.indd 20

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 20
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

20

Stop taking Angeliq and see a doctor
immediately
If you notice any of the following when taking HRT:
R any of the conditions mentioned in the ‘DO NOT
take Angeliq’ section
R yellowing of your skin or the whites of your eyes
(jaundice). These may be signs of a liver disease
R a large rise in your blood pressure (symptoms
may be headache, tiredness, dizziness)
R migraine-like headaches which happen for the
first time

43_02.indd 21

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 21
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

21

R if you become pregnant
R if you notice signs of a blood clot, such as
P painful swelling and redness of the legs
P sudden chest pain
P difficulty breathing
For more information see ‘Blood clots in a vein
(thrombosis)’
Note: Angeliq is not a contraceptive. If it is less
than 12 months since your last menstrual period
or you are under 50 years old, you may still need to
use additional contraception to prevent pregnancy.
Speak to your doctor for advice.

43_02.indd 22

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 22
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

22

HRT and cancer
Excessive thickening of the lining of the womb
(endometrial hyperplasia) and cancer of the
lining of the womb (endometrial cancer)
Taking oestrogen-only HRT will increase the risk
of excessive thickening of the lining of the womb
(endometrial hyperplasia) and cancer of the lining
of the womb (endometrial cancer).
The progestogen in Angeliq protects you from this
extra risk.

43_02.indd 23

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 23
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

23

Irregular bleeding
You may have irregular bleeding or drops of blood
(spotting) during the first 3–6 months of taking
Angeliq. However, if the irregular bleeding:
R Carries on for more than the first 6 months
R Starts after you have been taking Angeliq for
more than 6 months
R Carries on after you have stopped taking Angeliq
R See your doctor as soon as possible.

43_02.indd 24

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 24
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

24

Women who have breast cancer, or have had
breast cancer in the past, should not take HRT.
Evidence suggests that taking combined oestrogenprogestogen and possibly also oestrogen-only HRT
increases the risk of breast cancer. The extra risk
depends on how long you take HRT. The additional
risk becomes clear within a few years. However, it
returns to normal within a few years (at most 5)
after stopping treatment.

Breast cancer

43_02.indd 25

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 25
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

25

Your risk of breast cancer is also higher:
R if you have a close relative (mother, sister or
grandmother) who has had breast cancer
R if you are seriously overweight

43_02.indd 26

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 26
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

26

Compare
Looking at women aged 50 to 79 who are not
taking HRT, on average, 9 to 17 in 1000 will
be diagnosed with breast cancer over a 5-year
period.
For women aged 50 to 79 who are taking
oestrogen-progestogen HRT over 5 years, there
will be 13 to 23 cases in 1000 users (i.e. an
extra 4 to 6 cases).

43_02.indd 27

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 27
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

27

Regularly check your breasts. See your doctor, if
you notice any changes in your breast, such as:
R dimpling or sinking of the skin
R changes in the nipple
R any lumps you can see or feel
Additionally, you are advised to join mammography
screening programs when offered to you. For
mammogram screening, it is important that you
inform the nurse/healthcare professional who
is actually taking the x-ray that you use HRT, as
this medication may increase the density of your
breasts which may affect the outcome of the

43_02.indd 28

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 28
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

28

mammogram. Where the density of the breast
is increased, mammography may not detect all
lumps.

43_02.indd 29

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 29
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

29

Ovarian cancer
Ovarian cancer (cancer of the ovaries) is rare –
much rarer than breast cancer. It can be difficult
to diagnose, because there are often no obvious
signs of the disease. The use of oestrogen-only or
combined oestrogen-progestagen HRT has been
associated with a slightly increased risk of ovarian
cancer.

43_02.indd 30

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 30
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

30

The risk of ovarian cancer varies with age. For
example, in women aged 50 to 54 who are not
taking HRT, about 2 women in 2000 will be
diagnosed with ovarian cancer over a 5-year
period. For women who have been taking HRT
for 5 years, there will be about 3 cases per 2000
users (i.e. about 1 extra case).

43_02.indd 31

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 31
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

31

Effects of HRT on your heart or circulation
Blood clots in a vein (thrombosis)
The risk of blood clots in the veins (also called
deep vein thrombosis, or DVT) is about 1.3
to 3–times higher in HRT users than non-users,
especially during the first year of taking it.
Blood clots can be serious if one travels to the
lungs it can cause chest pain, breathlessness,
fainting or even death. This condition is called
pulmonary embolism or PE.
DVT and PE are examples of a condition called
venous thromboembolism, or VTE.

43_02.indd 32

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 32
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

32

You are more likely to get a blood clot in your veins
as you get older and if any of the following applies
to you. Inform your doctor if any of these situations
apply to you:
R you are unable to walk for a long time because
of major surgery, injury or illness (see also
sections 3, If you need to have surgery)
R you are seriously overweight (BMI >30kg/m²)
R you have any blood clotting problem that needs
long-term treatment with a medicine used to
prevent blood clots such as warfarin

43_02.indd 33

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 33
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

33

R if any of your close relatives has ever had a
blood clot in the leg, lung or another organ
R you have had one or more miscarriages
R you have systemic lupus erythematosus (SLE)
R you have cancer
For signs of a blood clot, see “Stop taking Angeliq
and see a doctor immediately”.

43_02.indd 34

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 34
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

34

Compare
Looking at women in their 50s who are not
taking HRT, on average, over a 5-year period, 4 to
7 in 1000 would be expected to get a blood clot
in a vein.
For women in their 50s who are taking
oestrogen-progestogen HRT, for over 5 years,
there will be 9 – 12 cases in 1000 (i.e. an extra
5 cases).

43_02.indd 35

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 35
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

35

Heart disease (heart attack)
There is no evidence that HRT will prevent a heart
attack.
HRT is not recommended for women who
have heart disease, or have had heart disease
recently. If you have ever had heart disease, talk to
your doctor to see if you should be taking HRT.
Women over the age of 60 years who use
oestrogen-progestogen HRT are slightly more likely
to develop heart disease than those not taking any
HRT.

43_02.indd 36

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 36
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

36

Studies with one type of HRT (containing
conjugated oestrogen plus the progestogen MPA)
have shown that women may be slightly more
likely to get heart disease during the first year of
taking the medication. For other types of HRT,
the risk is likely to be similar, although this is not
yet certain.

43_02.indd 37

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 37
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

37

If you get:
R a pain in your chest that spreads to your arm or
neck
R See a doctor as soon as possible and do not
take any more HRT until your doctor says you
can. This pain could be a sign of heart disease.

43_02.indd 38

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 38
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

38

Stroke
The risk of getting a stroke is about 1.5–times
higher in HRT users than in non–users. The number
of extra cases of stroke due to HRT use will increase
with age.
Other things that can increase the risk of stroke
include:
R getting older
R high blood pressure
R smoking
R drinking too much alcohol

43_02.indd 39

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 39
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

39

R an irregular heartbeat
If you are worried about any of these things, or
if you have had a stroke in the past, talk to your
doctor to see if you should take HRT.
Compare
Looking at women in their 50s who are not
taking HRT, on average, 8 in 1000 would be
expected to have a stroke over a 5-year period.
For women in their 50s who are taking HRT, there
will be 11 cases in 1000 users, over 5 years (i.e.
an extra 3 cases).

43_02.indd 40

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 40
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

40

If you get:
R unexplained migraine-type headaches, with or
without disturbed vision.
R weakness, numbness, or paralysis of the face,
arm, or leg
R dizziness, loss of balance or coordination
R See a doctor as soon as possible and do not
take any more HRT until your doctor says you
can. These headaches may be an early warning
sign of a stroke.

43_02.indd 41

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 41
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

41

Other conditions
R HRT will not prevent memory loss. There is
some evidence of a higher risk of memory loss in
women who start using HRT after the age of 65.
Speak to your doctor for advice.
R If you have heart or kidney problems, your
doctor should examine you carefully as
oestrogens may cause fluid retention resulting
in swelling.

43_02.indd 42

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 42
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

42

R If you have pre-existing elevated triglycerides
(a type of blood fat) your doctor should monitor
you closely during oestrogen replacement
therapy or HRT. Rare cases of large increases
of plasma triglycerides (hypertriglyceridemia)
leading to inflammation of the pancreas
(pancreatitis) have been reported with oestrogen
replacement therapy.

43_02.indd 43

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 43
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

43

R If you have a kidney disorder and have high
serum potassium levels, particularly if you are
taking ACE inhibitors, angiotensin II antagonists
and non-steroidal anti-inflammatory agents,
your doctor may check the potassium levels in
your blood during the first month of treatment.
R If you have high blood pressure, treatment
with Angeliq may decrease it. Angeliq should not
be used to treat high blood pressure.
R If you have a tendency to develop blotchy
brown patches (chloasma) on the face you
should avoid exposure to the sun or ultraviolet
light whilst using Angeliq.

43_02.indd 44

3/27/2017 9:52:21 AM

Packaging Technology Berlin sgqwx
page 44
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

44

Other medicines and Angeliq
Tell your doctor or pharmacist if you are taking,
have recently taken or might take any other
medicines. Some medicines may interfere with
the effect of Angeliq. This might lead to irregular
bleeding. This applies to the following medicines:
R medicines for epilepsy (such as barbiturates,
phenytoin, primidone, carbamazepine,
oxcarbazepine, topiramate and felbamate)
R medicines for tuberculosis (such as rifampicin,
rifabutin)

43_02.indd 45

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 45
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

45

R medicines for HIV and Hepatitis C Virus
infections (so-called protease inhibitors and
non-nucleoside reverse transcriptase inhibitors
such as nevirapine, efavirenz, nelfinavir and
ritonavir)
R medicines for inflammation or pain (such
as aspirin and other non-steriodal antiinflammatory drugs (NSAIDS)
R medicines for certain types of heart disease
or high blood pressure (ACE inhibitors or
angiotensin II receptor antagonists, verapamil,
diltiazem). If you are having treatment for high

43_02.indd 46

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 46
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

46

blood pressure and take Angeliq there may be
an additional decrease in blood pressure.
R Herbal remedies containing St. John’s wort
(Hypericum perforatum)
R medicines for treatment of fungal
infections (such as griseofulvin, itraconazole,
kenoconazole, voriconazole, fluconazole)
R medicines for treatment of bacterial
infections (such as clarithromycin,
erythromycin)
R grapefruit juice

43_02.indd 47

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 47
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

47

Laboratory tests
If you need a blood test, tell your doctor or the
laboratory staff that you are taking Angeliq,
because this medicine can affect the results of
some tests.

R Please tell your doctor or pharmacist if you
are taking or have recently taken any other
medicines including medicines obtained without
a prescription, herbal medicines or other natural
products.

43_02.indd 48

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 48
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

48

Driving or using machines
There is nothing to suggest that the use of Angeliq
affects driving or use of machines.

Pregnancy and breast-feeding
Angeliq is for use in post-menopausal women.
If you become pregnant, stop taking Angeliq
immediately and contact your doctor.

43_02.indd 49

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 49
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

49

Angeliq contains lactose
Angeliq contains lactose (a type of sugar). If you
have intolerance to some sugars, check with your
doctor before taking Angeliq.

43_02.indd 50

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 50
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

50

About the pack
This pack is designed to help you remember to take
your medicine. Each tablet is placed in a section
marked with the day of the week on which it should
be taken. The arrows between tablets show the
order in which they must be taken. Your doctor
may tell you when to start (see “when to start” for
further information).

Do not start taking Angeliq until at least 12
months after your last natural period.

3. How to take Angeliq

43_02.indd 51

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 51
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

51

On the day you start, take your first tablet from the
top row of tablets marked with the correct day. For
instance, if you start on a Tuesday, press out the
tablet from the blister marked ‘TUE’.
Take one tablet each day, following the directions
of the arrows, until you have finished all 28 tablets
in the pack. When you have finished each memo
strip, start the next memo strip on the following
day. Do not leave a break between memo strips.
It is best to take your tablet at the same time each
day. You can take Angeliq with or without food.

43_02.indd 52

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 52
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

52

If this is your first HRT treatment:
you can start your Angeliq tablets any day.

If you have been taking other HRT preparations:
carry on until you have finished your current pack
and have taken all the tablets for that month. Take
your first Angeliq tablet the next day. Do not leave
a break between your old tablets and the Angeliq
tablets.

When to start

The tablet should be swallowed whole with a glass
of water or milk.

43_02.indd 53

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 53
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

53

If you forget to take Angeliq
If you forget to take a tablet at your usual time and
you are less than 24 hours late, take it as soon as
possible. Take the next tablet at the usual time.

If you take more Angeliq than you should
If you have taken too many Angeliq tablets by
mistake, you may feel sick, vomit or have some
menstruation-like bleeding. No specific treatment
is necessary but you should consult your doctor or
pharmacist if you are worried.

43_02.indd 54

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 54
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

54

If you stop taking Angeliq
You may begin to feel the usual symptoms of the
menopause again, which may include hot flushes,
trouble sleeping, nervousness, dizziness or vaginal
dryness. Consult your doctor or pharmacist if you
want to stop taking Angeliq tablets. If you have

If you are more than 24 hours late, leave the
forgotten tablet in the pack. Continue to take the
rest of the tablets at the usual time every day.
If you forget to take your tablet for several days
you may experience irregular bleeding.

43_02.indd 55

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 55
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

55

If you need to have surgery
If you are going to have surgery, tell the surgeon
that you are taking Angeliq. You may need to
stop taking Angeliq about 4 to 6 weeks before the
operation to reduce the risk of a blood clot (see
section 2, “Blood clots in a vein (thrombosis)”).
Ask your doctor when you can start taking Angeliq
again.

any further questions on the use of this medicine,
ask your doctor or pharmacist.

43_02.indd 56

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 56
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

56

Like all medicines, Angeliq can cause side effects,
although not everybody gets them.
If any of the side effects gets serious, or if you
notice any side effects not listed in this booklet,
please tell your doctor or pharmacist.
The following diseases are reported more often in
women using HRT compared to women not using
HRT:

4. Possible side effects

43_02.indd 57

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 57
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

57

Serious side effects
R breast cancer
R abnormal growth or cancer of the lining of the
womb (endometrial hyperplasia or cancer)
R ovarian cancer
R blood clots in the veins of the leg or the lungs
(venous thromboembolism)
R heart disease
R stroke
R probable memory loss if HRT is started over the
age of 65

43_02.indd 58

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 58
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

58

Most frequent side effects (affecting more than
1 patient in every 10 patients):
R breakthrough bleeding at unexpected times (see
also section 2 "HRT and cancer”)
R breast tenderness

For more information about these side effects see
Section 2.
The following is a list of side effects that have been
linked to the use of Angeliq:

43_02.indd 59

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 59
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

59

R breast pains
These side effects occur during the first few
months of treatment with Angeliq. They are usually
temporary and normally disappear with continued
treatment. If they do not, contact your doctor.
Common side effects (affecting between 1 and 10
in every 100 patients):
R depression, mood changes, nervousness
R headache
R stomach ache, nausea, stomach enlargement
R non-cancerous breast tumour (benign breast
neoplasm), swollen breasts

43_02.indd 60

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 60
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

60

R increase in size of uterine fibroids
R non-cancerous growth of cells at the neck of the
womb (benign cervical growth)
R irregularities in your menstrual period
R vaginal discharge
R loss of energy, localised swelling.
Uncommon side effects (affecting between 1 and
10 in every 1000 patients):
R weight increase or decrease, loss or increase of
appetite for food, increase blood fats
R sleep problems, anxiety, decrease in sex drive

43_02.indd 61

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 61
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

61

R burning or pricking sensation, decreased
concentration, dizziness
R eye problems, visual disturbances (such as dry
eyes or blurred vision)
R palpitations
R blood clot, venous thrombosis (leg pain)
(also see section 2 “Blood clots in a vein
(thrombosis)”), high blood pressure, migraine,
inflammation of the veins, varicose veins
R breathlessness
R stomach disorder, diarrhoea, constipation,
vomiting, dry mouth, wind, altered sense of
taste

43_02.indd 62

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 62
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

62

R altered liver enzymes (will show up in blood
tests)
R skin problems, acne, hair loss, itchy skin, rash,
excessive hair or hair problems
R backache, pains in hands and feet, joint pain,
muscle cramps
R urinary tract disorders and infections
R thickening of the lining of the womb, thrush,
vaginal dryness and itchiness or burning of the
vagina.
R lumpy breast (fibrocystic breast), disorders of
the ovaries, cervix and uterus, pelvic pain

43_02.indd 63

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 63
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

63

R generalised fluid retention, chest pain, feeling
generally unwell, increase in sweating
R non-cancerous tumour of the womb (benign
uterine neoplasm)
Rare side effects (affecting between 1 and 10 in
every 10,000 patients):
R anaemia
R giddiness (vertigo)
R ringing in the ears (tinnitus)
R gall stones (cholelithiasis)
R muscle pain (myalgia)
R inflammation of the fallopian tubes (salpingitis)

43_02.indd 64

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 64
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

64

R milky discharge from the nipples (galactorrhoea)
R chills
The following side effects have occurred in clinical
trials of women with high blood pressure:
R high potassium levels (hyperkalaemia)
R heart failure, enlargement of the heart, heart
flutter, effects on heart rhythm
R increase in blood aldosterone

43_02.indd 65

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 65
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

65

(erythema multiforme)

R gall bladder disease
R various skin disorders
P discoloration of the skin especially of the
face or neck known as "pregnancy patches"
(chloasma)
P painful reddish skin nodules (erythema
nodosum)
P rash with target-shaped reddening or sores

The following side effects have been reported with other
HRTs:

43_02.indd 66

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 66
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

66

Yellow Card Scheme
Website: www.mhra.gov.uk/yellowcard

United Kingdom

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in
this leaflet. You can also report side effects directly (see
details below). By reporting side effects you can help
provide more information on the safety of this medicine.

Reporting of side effects

43_02.indd 67

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 67
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

67

ADR Reporting
Website: www.medicinesauthority.gov.mt/adrportal

Malta

43_02.indd 68

3/27/2017 9:52:22 AM

Packaging Technology Berlin sgqwx
page 68
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

68

Keep this medicine out of the sight and reach of
children.
Do not use this medicine after the expiry date
which is printed on the label after "EXP". The expiry
date refers to the last day of that month.
Do not throw away any medicines via wastewater
or household waste. Ask your pharmacist how to
throw away medicines you no longer use. These
measures will help to protect the environment.

5. How to store Angeliq

43_02.indd 69

3/27/2017 9:52:23 AM

Packaging Technology Berlin sgqwx
page 69
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

69

What Angeliq contains
The active substances are estradiol hemihydrate
and drospirenone.
The other ingredients are lactose monohydrate,
maize starch, pregelatinised maize starch, povidone
and magnesium stearate. The ingredients of the
tablet coating are hypromellose, macrogol 6000,
talc, titanium dioxide (E171) and red ferric oxide
(E172).

6. Contents of the pack and other
information

43_02.indd 70

3/27/2017 9:52:23 AM

Packaging Technology Berlin sgqwx
page 70
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

70

What Angeliq looks like and contents of the
pack
Angeliq tablets are red round convex coated
tablets.
One side is marked with the letters DL in a regular
hexagon.
They are supplied in a blister pack (memo strip)
containing 28 tablets with the days of the week
printed on the blister.
Boxes containing three blister packs are available.

43_02.indd 71

3/27/2017 9:52:23 AM

Packaging Technology Berlin sgqwx
page 71
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

71

Date of the last revision of this booklet
April 2017.

Manufacturer
Angeliq is made by: Bayer AG, Berlin, Germany.

Marketing Authorisation Holder
Bayer plc
Bayer House
Strawberry Hill
Newbury
Berkshire RG14 1JA

43_02.indd 72

3/27/2017 9:52:23 AM

Packaging Technology Berlin sgqwx
page 72
Bayer AG
client: 0021
material-no.: 85675443
PZ: 2537A-4C
code-no.: 173
name: LF-BRO-Angeliq 1/2 FTB 28
country: GB/-/BAG
colors: Black / Pantone 258 C
version: 27.03.2017/02
Restricted Document
dimension: 85 x 60 mm

72

85675443

+ Expand Transcript

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide